% alzhub.org library filter
% Source: https://alzhub.org/research?category=biomarkers&author=Perna+L
% 5 entries, in the order the page lists them. Built from alzhub.org's own records.
% 0 entries have no readable author in the source record and carry no author field.

@article{perna2023-37951931,
  author  = {Perna, L. and Stocker, H. and Burow, L. and Beyer, L. and Trares, K. and Kurz, C. and Gürsel, S. and Holleczek, B. and others},
  title   = {{Subjective cognitive complaints and blood biomarkers of neurodegenerative diseases: a longitudinal cohort study}},
  journal = {Alzheimer's research \& therapy},
  year    = {2023},
  doi     = {10.1186/s13195-023-01341-3},
  pmid    = {37951931},
  url     = {https://doi.org/10.1186/s13195-023-01341-3}
}

@article{stocker2023-36692879,
  author  = {Stocker, H. and Beyer, L. and Trares, K. and Perna, L. and Rujescu, D. and Holleczek, B. and Beyreuther, K. and Gerwert, K. and others},
  title   = {{Association of Kidney Function With Development of Alzheimer Disease and Other Dementias and Dementia-Related Blood Biomarkers}},
  journal = {JAMA network open},
  year    = {2023},
  doi     = {10.1001/jamanetworkopen.2022.52387},
  pmid    = {36692879},
  url     = {https://doi.org/10.1001/jamanetworkopen.2022.52387}
}

@article{stocker2023-37516890,
  author  = {Stocker, H. and Trares, K. and Beyer, L. and Perna, L. and Rujescu, D. and Holleczek, B. and Beyreuther, K. and Gerwert, K. and others},
  title   = {{Alzheimer's polygenic risk scores, APOE, Alzheimer's disease risk, and dementia-related blood biomarker levels in a population-based cohort study followed over 17 years}},
  journal = {Alzheimer's research \& therapy},
  year    = {2023},
  doi     = {10.1186/s13195-023-01277-8},
  pmid    = {37516890},
  url     = {https://doi.org/10.1186/s13195-023-01277-8}
}

@article{stocker2023-35234335,
  author  = {Stocker, H. and Beyer, L. and Perna, L. and Rujescu, D. and Holleczek, B. and Beyreuther, K. and Stockmann, J. and Schöttker, B. and others},
  title   = {{Association of plasma biomarkers, p-tau181, glial fibrillary acidic protein, and neurofilament light, with intermediate and long-term clinical Alzheimer's disease risk: Results from a prospective cohort followed over 17 years}},
  journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
  year    = {2023},
  doi     = {10.1002/alz.12614},
  pmid    = {35234335},
  url     = {https://doi.org/10.1002/alz.12614}
}

@article{nabers2018-29626112,
  author  = {Nabers, A. and Perna, L. and Lange, J. and Mons, U. and Schartner, J. and Güldenhaupt, J. and Saum, K. U. and Janelidze, S. and others},
  title   = {{Amyloid blood biomarker detects Alzheimer's disease}},
  journal = {EMBO molecular medicine},
  year    = {2018},
  doi     = {10.15252/emmm.201708763},
  pmid    = {29626112},
  url     = {https://doi.org/10.15252/emmm.201708763}
}